Chang, Y.-C.; Chuang, C.-H.; Huang, T.-Y.; Chung, C.-S.; Kuo, C.-J.; Pan, Y.-B.; Le, P.-H.
Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan. Biomedicines 2025, 13, 391.
https://doi.org/10.3390/biomedicines13020391
AMA Style
Chang Y-C, Chuang C-H, Huang T-Y, Chung C-S, Kuo C-J, Pan Y-B, Le P-H.
Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan. Biomedicines. 2025; 13(2):391.
https://doi.org/10.3390/biomedicines13020391
Chicago/Turabian Style
Chang, Yen-Cheng, Chiao-Hsiung Chuang, Tien-Yu Huang, Chen-Shuan Chung, Chia-Jung Kuo, Yu-Bin Pan, and Puo-Hsien Le.
2025. "Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan" Biomedicines 13, no. 2: 391.
https://doi.org/10.3390/biomedicines13020391
APA Style
Chang, Y.-C., Chuang, C.-H., Huang, T.-Y., Chung, C.-S., Kuo, C.-J., Pan, Y.-B., & Le, P.-H.
(2025). Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan. Biomedicines, 13(2), 391.
https://doi.org/10.3390/biomedicines13020391
